Latest News

September 20, 2021

Therapeutic Approvals: The US vs The UK

In a recent publication, Dr. Brian Callaghan looks at how the approach of approving drug therapies differs between the United State and the United Kingdom.

photo of Dr. Stephen Goutman
September 1, 2021

National ALS Registry Meeting 2021: Featuring Dr. Stephen Goutman

The National ALS Registry, managed by the Center for Disease Control (CDC) is one of the most important weapons in the fight against Amyotrophic Lateral Sclerosis (ALS). At the Annual Surveillance Meeting, Pranger ALS Clinic Director Dr. Stephen Goutman presented an update of important findings funded by the CDC.

July 22, 2021

World Brain Day 2021

In honor of World Brain Day, established by the World Federation of Neurology, we wanted to share a selection of brain imaging from our research.

July 13, 2021

Dr. Feldman featured on IASP Pain Research Forum Podcast

Speaking to the joint Harvard NeuroDiscovery Center and MassGeneral Institute for Neurodegenerative Disease Informatics group, Dr. Feldman discusses the problem of diabetic neuropathy, its causes and treatment, and our lab investigations of this condition.

June 28, 2021

ADA 2021: A Debate on Neuropathy Testing

Dr. Brian Callaghan shares his position about the current problems of diabetic neuropathy testing. He presented this argument during a debate at the American Diabetes Association's 81st Scientific Sessions.

June 14, 2021

New Grant: CLARiFY–An International Diabetes Collaboration

Funded by the NIDDK, CLARiFY is a multi-national collaborative grant that addresses the cognitive effects of Type 1 Diabetes. Along with our partners on the grant from Murdoch Children's Institute and Monash University (both in Australia), Dr. Eva Feldman discusses the problem and how we will will better understand this complication with a very

April 29, 2021

Post-COVID Care and Health Disparities

Watch Dr. Eva Feldman join Internal Medicine Chair Dr. John Carethers and fellow NeuroNetwork for Emerging Therapies Faculty Drs. Rodica Pop-Busui and Salim Hayek for a webinar on post-COVID care, Long COVID and health disparities.

World Voice Day Graphic
April 16, 2021

World Voice Day 2021: Dr. Norman Hogikyan

On World Voice Day, a message from a NeuroNetwork faculty member, Norman D. Hogikyan, M.D., FACS, Director of Michigan Medicine's Vocal Health Center.

Dr. Sarah Elzinga works with Biorepository samples at the NeuroNetwork for Emerging Therapies lab
April 16, 2021

Press: DMM First Person with Sarah Elzinga, PhD

Disease Models & Mechanisms selected Sarah Elzinga for a special Q&A about her recently published paper about the sex differences in insulin resistance, but not peripheral neuropathy in diet-induced prediabetes animal models

March 22, 2021

Dr.Eva Feldman Recaps NIH Long COVID Symposium

Early March, Dr. Feldman was invited to be a part of a meeting on "Long COVID" at the National Institutes of Health (NIH). In this video, she shares what she spoke about, what she learned, and what it means for the future of Michigan Medicine COVID-19 research.

Pages